Belgium
MyCellHub, founded in 2019, is a Belgium-based startup specializing in digitalizing and integrating data analytics in regulated laboratory and cleanroom workflows. With the slogan "Digital GMP workflows for streamlined manufacturing," the company directly addresses the inefficiencies of the biotech and (bio)pharmaceutical sectors, where over 90% of companies still utilize paper-based production reports. By digitizing these workflows, MyCellHub aims to expedite the launch of new therapies, reducing the industry's reliance on cumbersome paperwork.
The company operates primarily within the Analytics, Data Analytics, Manufacturing, and Telecom sectors. Their innovative approach has garnered attention, culminating in an acquisition investment from Title21 on 01 January 2026. As the demand for streamlined, efficient processes in the biotech and pharmaceutical fields continues to grow, MyCellHub is well-positioned to capitalize on the modernization of these industries.
